SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities

J Clin Invest. 2021 Apr 1;131(7):e148832. doi: 10.1172/JCI148832.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibodies, Neutralizing / biosynthesis
  • Antibodies, Neutralizing / blood
  • Antibodies, Viral / biosynthesis
  • Antibodies, Viral / blood
  • COVID-19 / immunology
  • COVID-19 / therapy*
  • COVID-19 / virology*
  • COVID-19 Serotherapy
  • Genome, Viral
  • Host Microbial Interactions / immunology
  • Humans
  • Immune Evasion
  • Immunization, Passive / adverse effects
  • Models, Immunological
  • Pandemics
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / immunology*
  • SARS-CoV-2 / pathogenicity

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral